光生物调节和低水平激光疗法作为糖尿病治疗的补充策略
Natalia Kurhaluk1, Vladimir Tomin2, Renata Kołodziejska3
1Institute of Biology, Pomeranian University in Słupsk, Arciszewski St. 22b, 76-200 Słupsk, Poland.
International journal of molecular sciences
|February 27, 2026
概括
低水平激光疗法 (LLLT) 和光生物调制疗法 (PBMT) 在治疗糖尿病并发症方面表现有前途. 这些激光疗法可以改善伤口愈合,减少疼痛,并增强代谢控制,副作用最小.
科学领域:
- 内分泌学和新陈代谢科学
- 生物医学工程 生物医学工程
- 照相医疗 (photomedicine) 是一种医学.
背景情况:
- 糖尿病患有慢性并发症,如神经病变和伤口愈合障碍,这给糖尿病带来了重大挑战.
- 目前用于糖尿病并发症的治疗方法在预防或逆转这些问题的有效性有限.
研究的目的:
- 审查基于激光的治疗方法的治疗潜力,特别是低水平激光疗法 (LLLT) 和光生物调节疗法 (PBMT),作为糖尿病管理的补充治疗方法.
- 分析支持激光治疗治疗糖尿病相关并发症的机制和临床证据.
主要方法:
- 对实验和临床研究的叙述性综述,调查糖尿病中的LLLT和PBMT.
- 分析与伤口愈合,神经病痛,血糖控制,血管功能和氧化应激相关的发现.
主要成果:
- 激光疗法在增强伤口愈合,缓解神经病痛,改善血糖控制和胰岛素敏感性方面表现出有效性.
- 机制包括线粒体激活,氧化释放,血管生成和炎症/氧化途径的调节.
- 激光疗法具有良好的安全性,副作用最小.
结论:
- LLLT和PBMT提供了一种安全的,互补的方法来管理糖尿病及其并发症.
- 治疗参数的标准化和更大的临床试验是广泛采用的必要条件.
- 建议将激光疗法与传统治疗相结合的个性化方案用于全面的糖尿病护理.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K